(Q34774462)

English

Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR. (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

15

object named as

Ann M Bode

1 reference

Europe PubMed Central

4 August 2017

17

object named as

Zigang Dong

1 reference

Europe PubMed Central

4 August 2017

9

object named as

Hanyong Chen

1 reference

Europe PubMed Central

4 August 2017

14

object named as

Yong-Yeon Cho

1 reference

Europe PubMed Central

4 August 2017

1

object named as

Sung Keun Jung

1 reference

Europe PubMed Central

4 August 2017

6

object named as

Sung-Young Lee

1 reference

Europe PubMed Central

4 August 2017

Joydeb Kumar Kundu

11

object named as

Joydeb Kumar Kundu

1 reference

Europe PubMed Central

4 August 2017

author name string

Mee-Hyun Lee

2

1 reference

Europe PubMed Central

4 August 2017

Do Young Lim

3

1 reference

Europe PubMed Central

4 August 2017

Jong Eun Kim

4

1 reference

Europe PubMed Central

4 August 2017

Puja Singh

5

1 reference

Europe PubMed Central

4 August 2017

Chul-Ho Jeong

7

1 reference

Europe PubMed Central

4 August 2017

Tae-Gyu Lim

8

1 reference

Europe PubMed Central

4 August 2017

Young-In Chi

10

1 reference

Europe PubMed Central

4 August 2017

Nam Hyouck Lee

12

1 reference

Europe PubMed Central

4 August 2017

Charles C Lee

13

1 reference

Europe PubMed Central

4 August 2017

Ki Won Lee

16

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

3 November 2014

1 reference

Europe PubMed Central

4 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

4 August 2017

289

1 reference

Europe PubMed Central

4 August 2017

52

1 reference

Europe PubMed Central

4 August 2017

35839-35848

1 reference

Europe PubMed Central

4 August 2017

The PI3k inhibitors: new hopes in the battle against advanced NSCLC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

A novel classification of lung cancer into molecular subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

T790M and acquired resistance of EGFR TKI: a literature review of clinical reports

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

MET signalling: principles and functions in development, organ regeneration and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

UCSF Chimera--a visualization system for exploratory research and analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Induction of cell cycle arrest and p21(CIP1/WAF1) expression in human lung cancer cells by isoliquiritigenin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

The Protein Data Bank

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4276852

7 July 2018

The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585513

21 January 2018

The presence of EGFR mutations predicts the response in Chinese non-small cell lung cancer patients treated with erlotinib.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585513

21 January 2018

Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585513

21 January 2018

Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1074/JBC.M114.585513

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34774462&oldid=1753522572"